Clinical relevance of reports on early access programs for checkpoint inhibitors in cancer patients: a French retrospective nationwide cohort study
French ATUs facilitated early access to new ICIs for many patients with cancer. However, data attrition hindered effective real-world monitoring.
Authors
- Christophe Tournigand
- Guillaume Lamé (ORCID: https://orcid.org/0000-0001-9514-1890)
- Gregory Manuceau
- Charlotte Fenioux (ORCID: https://orcid.org/0000-0001-6399-6843)
- Ahmed Bouras (ORCID: https://orcid.org/0000-0003-0243-8295)
- Adrien Monard (ORCID: https://orcid.org/0000-0001-6485-4951)
- Nicolas Albin (ORCID: https://orcid.org/0000-0003-0466-0068)
- Audrey Chatain (ORCID: https://orcid.org/0000-0002-2252-3254)
- Emmanuelle Kempf (ORCID: https://orcid.org/0000-0002-9285-1966)
- Samy Babai
- Enas Ahmed
Institutions
- Université Paris-Saclay (FR)
- Bouygues (France) (FR)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- CentraleSupélec (FR)
- Laboratoire Génie Industriel (FR)
- Institut de Chimie Moléculaire de Grenoble (FR)
- Hôpital Albert-Chenevier (FR)
Publication Details
- Journal
- ESMO Open
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1016/j.esmoop.2024.103711
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00